Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)

the coVAPid study group

doi:10.1186/s13054-021-03713-3

Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)

the coVAPid study group

Faculty of health sciences

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.

Original language	American English
Article number	284
Journal	Critical Care
Volume	25
Issue number	1
DOIs	https://doi.org/10.1186/s13054-021-03713-3
State	Indexed - Dec 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021

Access to Document

10.1186/s13054-021-03713-3

Fingerprint

Dive into the research topics of 'Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)'. Together they form a unique fingerprint.

Cite this

@article{8ba85ce25e11461abe2d1651ec255009,

title = "Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)",

abstract = "Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95\% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.",

author = "\{the coVAPid study group\} and Saad Nseir and Ignacio Martin-Loeches and Pedro Povoa and Matthieu Metzelard and \{Du Cheyron\}, Damien and Fabien Lambiotte and Fabienne Tamion and Marie Labruyere and Demosthenes Makris and \{Boulle Geronimi\}, Claire and \{Pinetonde Chambrun\}, Marc and Martine Nyunga and Olivier Pouly and Bruno M{\'e}garbane and Anastasia Saade and Gemma Gom{\`a} and Eleni Magira and Llitjos, \{Jean Fran{\c c}ois\} and Antoni Torres and Iliana Ioannidou and Alexandre Pierre and Luis Coelho and Jean Reignier and Denis Garot and Louis Kreitmann and Baudel, \{Jean Luc\} and Guillaume Voiriot and Damien Contou and Alexandra Beurton and Pierre Asfar and Alexandre Boyer and Thille, \{Arnaud W.\} and Armand Mekontso-Dessap and Vassiliki Tsolaki and Christophe Vinsonneau and Floch, \{Pierre Edouard\} and \{Le Guennec\}, Lo{\"i}c and Adrian Ceccato and Antonio Artigas and Mathilde Bouchereau and Julien Labreuche and Alain Duhamel and Anahita Rouz{\'e} and Rapha{\"e}l Favory and S{\'e}bastien Pr{\'e}au and Merc{\'e} Jourdain and Julien Poissy and Leger, \{Piehr Saint\} and \{Van der Linden\}, Thierry and Catia Cilloniz",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = dec,

doi = "10.1186/s13054-021-03713-3",

language = "American English",

volume = "25",

journal = "Critical Care",

issn = "1364-8535",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)

AU - the coVAPid study group

AU - Nseir, Saad

AU - Martin-Loeches, Ignacio

AU - Povoa, Pedro

AU - Metzelard, Matthieu

AU - Du Cheyron, Damien

AU - Lambiotte, Fabien

AU - Tamion, Fabienne

AU - Labruyere, Marie

AU - Makris, Demosthenes

AU - Boulle Geronimi, Claire

AU - Pinetonde Chambrun, Marc

AU - Nyunga, Martine

AU - Pouly, Olivier

AU - Mégarbane, Bruno

AU - Saade, Anastasia

AU - Gomà, Gemma

AU - Magira, Eleni

AU - Llitjos, Jean François

AU - Torres, Antoni

AU - Ioannidou, Iliana

AU - Pierre, Alexandre

AU - Coelho, Luis

AU - Reignier, Jean

AU - Garot, Denis

AU - Kreitmann, Louis

AU - Baudel, Jean Luc

AU - Voiriot, Guillaume

AU - Contou, Damien

AU - Beurton, Alexandra

AU - Asfar, Pierre

AU - Boyer, Alexandre

AU - Thille, Arnaud W.

AU - Mekontso-Dessap, Armand

AU - Tsolaki, Vassiliki

AU - Vinsonneau, Christophe

AU - Floch, Pierre Edouard

AU - Le Guennec, Loïc

AU - Ceccato, Adrian

AU - Artigas, Antonio

AU - Bouchereau, Mathilde

AU - Labreuche, Julien

AU - Duhamel, Alain

AU - Rouzé, Anahita

AU - Favory, Raphaël

AU - Préau, Sébastien

AU - Jourdain, Mercé

AU - Poissy, Julien

AU - Leger, Piehr Saint

AU - Van der Linden, Thierry

AU - Cilloniz, Catia

PY - 2021/12

Y1 - 2021/12

N2 - Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.

AB - Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.

UR - https://www.scopus.com/pages/publications/85112582450

U2 - 10.1186/s13054-021-03713-3

DO - 10.1186/s13054-021-03713-3

M3 - Comment/debate

C2 - 34372897

AN - SCOPUS:85112582450

SN - 1364-8535

VL - 25

JO - Critical Care

JF - Critical Care

IS - 1

M1 - 284

ER -